Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Early Detection of Cancer | 8 | 2022 | 392 | 2.530 |
Why?
|
Colorectal Neoplasms | 8 | 2022 | 938 | 2.380 |
Why?
|
Aortic Aneurysm, Thoracic | 9 | 2021 | 87 | 2.130 |
Why?
|
Emigrants and Immigrants | 6 | 2018 | 44 | 1.840 |
Why?
|
Blood Vessel Prosthesis Implantation | 9 | 2021 | 208 | 1.780 |
Why?
|
Transcatheter Aortic Valve Replacement | 7 | 2021 | 47 | 1.700 |
Why?
|
Endovascular Procedures | 10 | 2021 | 218 | 1.630 |
Why?
|
Aortic Valve | 8 | 2021 | 222 | 1.340 |
Why?
|
Aortic Aneurysm | 5 | 2020 | 80 | 1.260 |
Why?
|
Patient Navigation | 3 | 2018 | 12 | 1.250 |
Why?
|
Colonoscopy | 3 | 2022 | 264 | 1.080 |
Why?
|
Aortic Valve Stenosis | 3 | 2021 | 131 | 1.070 |
Why?
|
Heart Valve Prosthesis Implantation | 4 | 2020 | 166 | 1.040 |
Why?
|
Heart Valve Prosthesis | 5 | 2021 | 93 | 0.750 |
Why?
|
Hepatitis B, Chronic | 2 | 2018 | 32 | 0.730 |
Why?
|
Computed Tomography Angiography | 4 | 2022 | 131 | 0.710 |
Why?
|
Aortography | 2 | 2018 | 63 | 0.690 |
Why?
|
Communication Barriers | 1 | 2018 | 29 | 0.640 |
Why?
|
Chicago | 7 | 2020 | 1379 | 0.630 |
Why?
|
Intention | 1 | 2018 | 51 | 0.620 |
Why?
|
Health Education | 1 | 2018 | 100 | 0.610 |
Why?
|
Middle Aged | 30 | 2021 | 25017 | 0.610 |
Why?
|
Software | 1 | 2021 | 654 | 0.580 |
Why?
|
Public Health Surveillance | 1 | 2016 | 21 | 0.570 |
Why?
|
Bioprosthesis | 3 | 2021 | 36 | 0.560 |
Why?
|
Aged | 22 | 2021 | 18402 | 0.550 |
Why?
|
Humans | 53 | 2022 | 86601 | 0.550 |
Why?
|
Education, Public Health Professional | 1 | 2015 | 2 | 0.540 |
Why?
|
Women's Health | 1 | 2016 | 100 | 0.530 |
Why?
|
Community-Based Participatory Research | 1 | 2015 | 36 | 0.520 |
Why?
|
Urban Health | 1 | 2015 | 55 | 0.520 |
Why?
|
Gastrointestinal Diseases | 1 | 2016 | 146 | 0.510 |
Why?
|
Colonic Polyps | 1 | 2015 | 126 | 0.490 |
Why?
|
Female | 35 | 2022 | 44507 | 0.490 |
Why?
|
Mass Screening | 4 | 2020 | 617 | 0.480 |
Why?
|
Male | 35 | 2022 | 40956 | 0.470 |
Why?
|
Retrospective Studies | 19 | 2022 | 8475 | 0.450 |
Why?
|
Health Status Disparities | 1 | 2015 | 170 | 0.450 |
Why?
|
Primary Health Care | 1 | 2016 | 339 | 0.440 |
Why?
|
Michigan | 7 | 2021 | 52 | 0.440 |
Why?
|
Treatment Outcome | 16 | 2022 | 7988 | 0.430 |
Why?
|
Education, Medical | 1 | 2015 | 233 | 0.420 |
Why?
|
Stents | 4 | 2021 | 377 | 0.390 |
Why?
|
Aorta | 3 | 2021 | 280 | 0.380 |
Why?
|
Endocarditis, Bacterial | 2 | 2020 | 33 | 0.380 |
Why?
|
Hospital Mortality | 7 | 2020 | 348 | 0.380 |
Why?
|
Blood Vessel Prosthesis | 3 | 2021 | 228 | 0.360 |
Why?
|
Minority Groups | 3 | 2020 | 137 | 0.360 |
Why?
|
Pain, Postoperative | 3 | 2021 | 240 | 0.360 |
Why?
|
Acute Disease | 6 | 2022 | 826 | 0.330 |
Why?
|
Time Factors | 9 | 2021 | 5209 | 0.330 |
Why?
|
Mesenteric Ischemia | 2 | 2018 | 4 | 0.320 |
Why?
|
Religion and Psychology | 1 | 2006 | 18 | 0.290 |
Why?
|
Community-Institutional Relations | 1 | 2006 | 29 | 0.290 |
Why?
|
Analgesics, Opioid | 2 | 2021 | 413 | 0.290 |
Why?
|
Behavior Therapy | 1 | 2006 | 75 | 0.280 |
Why?
|
Cardiac Surgical Procedures | 2 | 2021 | 462 | 0.280 |
Why?
|
Follow-Up Studies | 5 | 2020 | 3636 | 0.280 |
Why?
|
Rural Population | 1 | 2006 | 136 | 0.280 |
Why?
|
China | 3 | 2020 | 228 | 0.270 |
Why?
|
Spirituality | 1 | 2006 | 87 | 0.270 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2006 | 39 | 0.270 |
Why?
|
Ischemia | 2 | 2018 | 243 | 0.270 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2006 | 42 | 0.270 |
Why?
|
Religion and Medicine | 1 | 2006 | 122 | 0.260 |
Why?
|
United States | 9 | 2020 | 6665 | 0.260 |
Why?
|
Weight Loss | 1 | 2006 | 229 | 0.260 |
Why?
|
Healthcare Disparities | 4 | 2016 | 370 | 0.250 |
Why?
|
Insurance Coverage | 2 | 2015 | 115 | 0.250 |
Why?
|
Aorta, Thoracic | 2 | 2021 | 165 | 0.230 |
Why?
|
Adult | 10 | 2020 | 25640 | 0.230 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2015 | 508 | 0.230 |
Why?
|
Evidence-Based Medicine | 3 | 2020 | 429 | 0.230 |
Why?
|
Curriculum | 3 | 2015 | 539 | 0.220 |
Why?
|
Risk Factors | 8 | 2021 | 5416 | 0.220 |
Why?
|
Risk Assessment | 5 | 2018 | 2261 | 0.210 |
Why?
|
Text Messaging | 1 | 2022 | 27 | 0.210 |
Why?
|
Genetic Testing | 1 | 2006 | 535 | 0.200 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2021 | 29 | 0.200 |
Why?
|
Diverticulum | 1 | 2021 | 44 | 0.200 |
Why?
|
Long Term Adverse Effects | 1 | 2020 | 6 | 0.190 |
Why?
|
Hepatitis B Surface Antigens | 2 | 2018 | 24 | 0.190 |
Why?
|
Intercostal Nerves | 1 | 2020 | 3 | 0.190 |
Why?
|
Endocarditis | 1 | 2020 | 18 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 189 | 0.180 |
Why?
|
Deglutition Disorders | 1 | 2021 | 115 | 0.180 |
Why?
|
Risk | 2 | 2020 | 674 | 0.180 |
Why?
|
Aged, 80 and over | 6 | 2021 | 6501 | 0.180 |
Why?
|
Neoplasms | 1 | 2015 | 2897 | 0.180 |
Why?
|
Denervation | 1 | 2020 | 34 | 0.180 |
Why?
|
Vulnerable Populations | 1 | 2020 | 76 | 0.180 |
Why?
|
Obesity | 1 | 2006 | 963 | 0.180 |
Why?
|
Cryosurgery | 1 | 2020 | 40 | 0.180 |
Why?
|
Abscess | 1 | 2020 | 91 | 0.180 |
Why?
|
Cerebrovascular Disorders | 1 | 2020 | 143 | 0.180 |
Why?
|
Marketing of Health Services | 1 | 2019 | 15 | 0.180 |
Why?
|
Prosthesis-Related Infections | 1 | 2020 | 58 | 0.180 |
Why?
|
Patient Admission | 1 | 2020 | 112 | 0.180 |
Why?
|
Panax | 2 | 2011 | 170 | 0.180 |
Why?
|
Narcotics | 1 | 2020 | 69 | 0.180 |
Why?
|
Postoperative Complications | 5 | 2021 | 2207 | 0.170 |
Why?
|
Prosthesis Failure | 1 | 2020 | 111 | 0.170 |
Why?
|
Hospitals, High-Volume | 1 | 2019 | 35 | 0.170 |
Why?
|
Disease Outbreaks | 1 | 2020 | 154 | 0.170 |
Why?
|
Cerebrovascular Circulation | 1 | 2020 | 212 | 0.170 |
Why?
|
Splanchnic Circulation | 1 | 2018 | 16 | 0.170 |
Why?
|
Informed Consent | 1 | 2021 | 266 | 0.170 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 351 | 0.170 |
Why?
|
Pain Management | 1 | 2020 | 127 | 0.170 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2020 | 112 | 0.160 |
Why?
|
Chronic Disease | 2 | 2020 | 970 | 0.160 |
Why?
|
Occult Blood | 1 | 2018 | 16 | 0.160 |
Why?
|
Endothelial Cells | 1 | 2021 | 428 | 0.160 |
Why?
|
Aortic Rupture | 1 | 2018 | 55 | 0.160 |
Why?
|
Device Removal | 1 | 2020 | 161 | 0.160 |
Why?
|
Hospitals, University | 1 | 2018 | 194 | 0.160 |
Why?
|
Vascular Calcification | 1 | 2018 | 39 | 0.160 |
Why?
|
Registries | 1 | 2021 | 702 | 0.160 |
Why?
|
Quantitative Trait Loci | 1 | 2021 | 576 | 0.150 |
Why?
|
Forecasting | 1 | 2018 | 304 | 0.150 |
Why?
|
Health Expenditures | 1 | 2018 | 86 | 0.150 |
Why?
|
Community Health Services | 1 | 2018 | 80 | 0.150 |
Why?
|
Viscera | 1 | 2016 | 17 | 0.150 |
Why?
|
Influenza, Human | 1 | 2020 | 329 | 0.150 |
Why?
|
Reoperation | 4 | 2020 | 597 | 0.150 |
Why?
|
Prognosis | 3 | 2020 | 3674 | 0.150 |
Why?
|
Hospitals | 1 | 2019 | 294 | 0.140 |
Why?
|
Seroepidemiologic Studies | 1 | 2016 | 55 | 0.140 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 864 | 0.140 |
Why?
|
Patient Participation | 1 | 2018 | 216 | 0.140 |
Why?
|
Directive Counseling | 1 | 2016 | 34 | 0.140 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 451 | 0.140 |
Why?
|
Risk Reduction Behavior | 1 | 2016 | 98 | 0.130 |
Why?
|
Cambodia | 1 | 2015 | 5 | 0.130 |
Why?
|
Vietnam | 1 | 2015 | 14 | 0.130 |
Why?
|
Polyps | 1 | 2015 | 28 | 0.130 |
Why?
|
Referral and Consultation | 1 | 2018 | 326 | 0.130 |
Why?
|
Thrombosis | 1 | 2018 | 296 | 0.130 |
Why?
|
Kidney Failure, Chronic | 1 | 2020 | 509 | 0.130 |
Why?
|
Cultural Diversity | 2 | 2013 | 51 | 0.130 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2015 | 66 | 0.130 |
Why?
|
Schools, Medical | 2 | 2013 | 123 | 0.130 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 295 | 0.120 |
Why?
|
Universities | 1 | 2015 | 135 | 0.120 |
Why?
|
Communication | 1 | 2018 | 440 | 0.120 |
Why?
|
Logistic Models | 1 | 2018 | 1185 | 0.120 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 1673 | 0.120 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 1034 | 0.120 |
Why?
|
Sexual and Gender Minorities | 1 | 2016 | 192 | 0.110 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 567 | 0.110 |
Why?
|
Personnel Selection | 1 | 2013 | 59 | 0.110 |
Why?
|
Reproducibility of Results | 1 | 2018 | 2705 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 1373 | 0.100 |
Why?
|
Age Factors | 1 | 2016 | 1849 | 0.100 |
Why?
|
Dietary Fats | 1 | 2011 | 135 | 0.100 |
Why?
|
Faculty, Medical | 1 | 2013 | 178 | 0.100 |
Why?
|
Decision Making | 1 | 2016 | 642 | 0.090 |
Why?
|
School Admission Criteria | 1 | 2010 | 23 | 0.090 |
Why?
|
Down-Regulation | 1 | 2011 | 504 | 0.090 |
Why?
|
Ginsenosides | 1 | 2011 | 123 | 0.090 |
Why?
|
Plant Extracts | 1 | 2011 | 244 | 0.090 |
Why?
|
Sex Factors | 1 | 2012 | 1054 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 427 | 0.090 |
Why?
|
Pain Measurement | 2 | 2020 | 321 | 0.080 |
Why?
|
ErbB Receptors | 1 | 2011 | 485 | 0.080 |
Why?
|
Physicians | 1 | 2016 | 673 | 0.080 |
Why?
|
Regional Blood Flow | 2 | 2018 | 197 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2011 | 556 | 0.070 |
Why?
|
North Carolina | 1 | 2006 | 50 | 0.070 |
Why?
|
Diet, Reducing | 1 | 2006 | 31 | 0.070 |
Why?
|
Prospective Studies | 1 | 2015 | 4210 | 0.070 |
Why?
|
Focus Groups | 1 | 2006 | 155 | 0.070 |
Why?
|
Education, Medical, Undergraduate | 1 | 2008 | 160 | 0.070 |
Why?
|
Practice Patterns, Physicians' | 2 | 2021 | 581 | 0.070 |
Why?
|
Sex Distribution | 1 | 2006 | 173 | 0.070 |
Why?
|
Family Health | 1 | 2006 | 162 | 0.070 |
Why?
|
Survival Rate | 2 | 2020 | 1860 | 0.070 |
Why?
|
Leadership | 1 | 2006 | 134 | 0.070 |
Why?
|
Students, Medical | 1 | 2010 | 384 | 0.060 |
Why?
|
Young Adult | 1 | 2016 | 5974 | 0.060 |
Why?
|
Internal Medicine | 1 | 2008 | 347 | 0.060 |
Why?
|
Adolescent | 1 | 2016 | 8979 | 0.060 |
Why?
|
Exercise | 1 | 2006 | 315 | 0.060 |
Why?
|
Cohort Studies | 2 | 2020 | 2767 | 0.060 |
Why?
|
Body Mass Index | 1 | 2006 | 770 | 0.060 |
Why?
|
Cathartics | 1 | 2022 | 27 | 0.050 |
Why?
|
Subclavian Artery | 1 | 2021 | 44 | 0.050 |
Why?
|
bcl-2-Associated X Protein | 1 | 2021 | 47 | 0.050 |
Why?
|
Caspase 3 | 1 | 2021 | 159 | 0.050 |
Why?
|
Aftercare | 1 | 2021 | 85 | 0.050 |
Why?
|
Medical Overuse | 1 | 2020 | 36 | 0.050 |
Why?
|
Introns | 1 | 2021 | 289 | 0.050 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2021 | 231 | 0.050 |
Why?
|
Substance Abuse, Intravenous | 1 | 2020 | 54 | 0.040 |
Why?
|
Prosthesis Design | 1 | 2020 | 278 | 0.040 |
Why?
|
Surveys and Questionnaires | 2 | 2020 | 2501 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2020 | 193 | 0.040 |
Why?
|
Vascular Grafting | 1 | 2018 | 15 | 0.040 |
Why?
|
Patient Discharge | 1 | 2021 | 300 | 0.040 |
Why?
|
Episode of Care | 1 | 2018 | 7 | 0.040 |
Why?
|
Seasons | 1 | 2020 | 223 | 0.040 |
Why?
|
Hepatitis B Vaccines | 1 | 2018 | 13 | 0.040 |
Why?
|
Hepatitis B virus | 1 | 2018 | 43 | 0.040 |
Why?
|
Vascular Surgical Procedures | 1 | 2019 | 148 | 0.040 |
Why?
|
Quality Improvement | 1 | 2022 | 428 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 860 | 0.040 |
Why?
|
Time-to-Treatment | 1 | 2018 | 97 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2006 | 2270 | 0.040 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 384 | 0.040 |
Why?
|
Program Evaluation | 1 | 2018 | 297 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2021 | 1804 | 0.040 |
Why?
|
Critical Pathways | 1 | 2016 | 35 | 0.040 |
Why?
|
Stereotyping | 1 | 2016 | 13 | 0.040 |
Why?
|
Genome, Human | 1 | 2021 | 756 | 0.040 |
Why?
|
Health Communication | 1 | 2016 | 13 | 0.040 |
Why?
|
Clinical Decision-Making | 1 | 2018 | 257 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2016 | 29 | 0.040 |
Why?
|
Culture | 1 | 2016 | 53 | 0.030 |
Why?
|
Kidney | 1 | 2022 | 1241 | 0.030 |
Why?
|
Length of Stay | 1 | 2018 | 700 | 0.030 |
Why?
|
Survival Analysis | 1 | 2018 | 1538 | 0.030 |
Why?
|
Patient Selection | 1 | 2018 | 685 | 0.030 |
Why?
|
Insurance, Health | 1 | 2015 | 160 | 0.030 |
Why?
|
Pandemics | 1 | 2020 | 740 | 0.030 |
Why?
|
Incidence | 1 | 2018 | 1576 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 1620 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 1920 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 364 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2015 | 394 | 0.030 |
Why?
|
Qualitative Research | 1 | 2013 | 256 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2013 | 319 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 610 | 0.020 |
Why?
|
Heart Failure | 1 | 2020 | 1203 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2011 | 188 | 0.020 |
Why?
|
Mutation | 1 | 2021 | 3967 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2011 | 315 | 0.020 |
Why?
|
Administration, Oral | 1 | 2011 | 684 | 0.020 |
Why?
|
Data Collection | 1 | 2010 | 372 | 0.020 |
Why?
|
Algorithms | 1 | 2016 | 1830 | 0.020 |
Why?
|
Colon | 1 | 2011 | 496 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 2600 | 0.020 |
Why?
|
Bacteria | 1 | 2011 | 447 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 1621 | 0.020 |
Why?
|
HIV Infections | 1 | 2016 | 772 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 3352 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 2426 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 797 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2011 | 2232 | 0.020 |
Why?
|
Mice | 1 | 2011 | 11352 | 0.010 |
Why?
|
Animals | 1 | 2011 | 26581 | 0.010 |
Why?
|